China's scientific research and high-tech industries - Page 6

oneman28 · 12-18-2005, 10:11 AM

http://www.tmcnet.com/usubmit/2005/dec/1224426.htm

(

Quote:

Comtex Business)CHONGQING, Dec 15, 2005 (SinoCast China IT Watch via COMTEX) --After a short talk with the local government, the producer and marketer for Chinese homegrown microprocessor series just decided to establish a research and development base in Chongqing, a major city in southwestern China.

The best-known Chinese microprocessor is the Godson-2 (also known as the Dragon chip), which is a 64-bit microprocessor developed by a team of researchers at the Institute of Computing Technology (ICT), part of the Chinese Academy of Sciences (CAS) in Beijing.

While ICT handles the design of the Godson chips, the responsibility for sales and marketing belongs to an ICT spin- off company, BLX IC Design Co. Ltd. (BLX), which is headed by Eddie Zeng, a former Intel Corp. executive.

Since the Godson-2 chip debuted in this April, ICT and BLX started seeking proper places to shape a more integrated base for the Godson chip industry.

Then in this October, Chongqing started construction of the Xiyong Microelectronics Industrial Park. The industrial park is expected to open in 2010 as a manufacturing and R&D park for IC design, software development, chip manufacturing and electronics manufacturing.

Eddie Zeng and Chongqing local officials had their deal made on almost the first time they met. "I think this is partly because that I myself was born in Chongqing," Eddie Zeng revealed jokingly.

Under the cooperative frame, BLX will launch a downline company named Chongqing Godson IC Co., Ltd. in the industrial park, with CNY10 million initial investments.

"The new subsidiary will doing the chip system designing work at first," said a BLX official, "Later, it will be in charge of the software designing and finally, the whole Godson-3 CPU will be developed there, if things go smoothly."

As scheduled, Chongqing municipal government will invest USD8 million to construct the industrial park. The park already has commitments from semiconductor and software companies totaling USD2.3 billion in value. Production value from the park is expected to reach CNY100 billion to CNY150 billion in 2010.

The first member of the Godson family, the 32-bit Godson-1 processor, was introduced in 2002. It ran at a clock speed of 266MHz and was produced by contract chip manufacturer Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC).

The latest addition to the family, the Godson-2, is produced by another contract chip maker, Shanghai-based Semiconductor Manufacturing International Corp. (SMIC). Been manufactured through a 180-nanometer process, the Godson-2 runs at a clock speed up to 500MHz but it is based on different instruction set that is not compatible with x86. As a result, the chip is intended for use in applications such as a set-top box rather than a personal computer.

As for the Godson-3, it was rumored that it will apply a four-core structure and hardware-assisted simultaneous multithreading technology.

"By the end of next year, we hope we can add in multiprocessor support and on-chip secondary cache. If these features are added, the new chip's power consumption may be around 10 watts," said Tang Zhimin, a senior ICT engineer who headed up the Godson project. The power budget for Godson-2 is around 5 watts, based on a 1.8V core and 3.3V I/O.

"We are also looking at how to integrate multithreading with our current superscalar architecture," Tang said.

Besides, the Godson designers also are working on a second version of the Godson-2. That chip will be produced next year using a 130-nanometer process and run at a clock speed of up to 1GHz. It will also include a faster front-side bus, more cache, and support for DDR (Double Data Rate) memory.

International analysts believe the Chinese already are capable of designing world-class microprocessors, assuming they have access to world-class fabrication technology. Although Chinese fabs are about two process generations behind the curve, China's technology is rapidly accelerating.

SMIC announced earlier that it would start massive production of 90-nanometer chips at the beginning of next year and launch its first 65-nanometer sample no later than 2006- end.

From eNet.com.cn, Page 1, Wednesday, December 14, 2005
info@SinoCast.com

oneman28 · 12-18-2005, 13:57 PM

THE CNC lathe has a precison of 0.01 micron as thin as 0.1 per cent of a hair,which is the basic facilities to manufacture modern air engine.Obviously ,this is breakthrough of Chinese equipment industry.

The CNC Lathe was first developed in the early 1980' in U.S. and has been laid enbargo on China by the western countries for over 20 years.

The CNC Lathe developed this time is the masterpieces of "National Engineering Research Center For High-End CNC" .Especially,the price of NC Lathe developed by the Research Center is just 30% of the counterpart of western countries.

more introduction:
http://lt-cnc.sict.ac.cn/products/en_products.asp

CCTV report in Chinese:
mms://winmedia.cctv.com.cn/xinwenlia...0051125_16.wmv

oneman28 · 12-19-2005, 05:16 AM

URL: http://www.eetimes.com/showArticle.j...leID=172901102

Quote:

Dylan McGrath
(10/27/2005 6:47 PM EDT)

SAN FRANCISCO — Semiconductor Manufacturing International Corp. (SMIC) President and CEO Richard Chang said Thursday (Oct. 27) that his company would deliver 65-nanometer engineering samples in 2006.

As part of the company's earnings announcement Thursday, Chang said SMIC has recently entered into an agreement with an unnamed customer to co-develop a 65-nm process and deliver engineering samples by the end of next year.

The announcement comes as a surprise to industry observers — SMIC and other Chinese foundries are widely assumed to be well behind the rest of the world in the development of leading-edge process technology.

Taiwanese foundry giants Taiwan Semiconductor Manufacturing Co. (TSMC) and United Microelectronics Corp. (UMC) have recently begun sampling 65-nm. TSMC said earlier this month that it has completed the first run of its 65-nm CyberShuttle prototyping service carrying customer designs and UMC said Wednesday that it has delivered the first 65-nm product samples to customers.

In a conference call following the earnings announcement, Chang said SMIC would focus its 65-nm efforts on a few customers that have higher volume requirements.

Chang also said Thursday that SMIC would commence pilot product on 90-nm by the end of 2005, with commercial production to being slightly thereafter. He said SMIC's 90-nm qualification lot yields have exceeded customer and are "comparable to the industry average."

Chang said SMIC would use its 90-nm logic process with technology licensed from Saifun Semiconductors to manufacture a 2 gigabit NAND flash product. The company has also entered into a definitive agreement with Elpida to migrate its capacity from 100-nm to the 90-nm process at SMIC's Fab 4 in Beijing, he said.

In the third quarter, 130-nanometer logic products accounted for 15 percent of the company's revenue.

SMIC, China's No. 1 foundry, reported Thursday third quarter sales of $310 million, up 11 percent from the $279.5 million in sales that the company posted for the second quarter. The company posted a net loss for the quarter of $26.1 million, down 35 percent from the $40.4 million net loss it posted for the second quarter.

oneman28 · 12-23-2005, 11:27 AM

http://www.theaustralian.news.com.au...E36375,00.html

Quote:

Mure Dickie, Beijing
December 24, 2005
CHINA has quietly begun building large-scale trial networks based on a home-grown third-generation mobile telephone standard, industry players say.

Construction of the networks in Shanghai and other cities is the strongest evidence yet of China's determination to create a central role for the TD-SCDMA standard as part of its 3G rollout.

It will also fuel expectations that Beijing plans to issue a TD-SCDMA licence to China Telecom, the leading fixed-line operator, which is running the Shanghai trial along with two other phone companies.

The Shanghai trial involves two core networks and 16 "base stations" that cover commercial districts, development zones and residential neighbourhoods, one industry player said.

"They started with Shanghai and are also drawing up plans for other cities," said another source. "The trial networks will be progressively expanded to a pretty big scale."

BDA China, a telecoms consultancy, said by introducing TD-SCDMA, Beijing hoped to give China Telecom an edge over domestic rivals that use foreign-backed standards, and to support local equipment providers.

A headstart would help to make up for the lack of maturity of TD-SCDMA technology compared with the rival European-backed WCDMA and US-supported CDMA-2000 standards.

It would be good news for local equipment vendors such as Datang Telecom, TD-SCDMA's biggest backer, and ZTE, which makes products for the other 3G standards but is strong in TD-SCDMA and is supplying the equipment for the Shanghai trial.

Equipment vendors have been awaiting the arrival of 3G in China, the world's most populous telecoms market in terms of subscribers, with each local operator likely to spend about 50 billion yuan ($8.5 billion) over two or three years to build a national network.

Beijing's telecoms regulators remain tight-lipped about their plans, but there have been increasing signs of likely action.

State media this week quoted Information Industry Vice-Minister Xi Guohua as saying "decision time" had arrived for 3G licensing policy and that TD-SCDMA must play a central role.

"Now the technology and the industrial chain for this standard has taken shape," Mr Xi said. "TD-SCDMA must take a place in Chinese 3G and it may be run by a strong operator."

His remarks were seen as a signal that China Telecom would be soon allowed to build a nationwide 3G network.

oneman28 · 12-26-2005, 13:14 PM

http://www.kfmb.com/story.php?id=32048

Quote:

12-26-05 at 7:09AM

A new bird flu vaccine for poultry may help in the development of a vaccine to protect people.

Officials in China said the country will begin mass-producing the new vaccine within the next week. The vaccine will be used alongside existing medicines.

Since October, China said it has vaccinated more than 5 billion birds.

There have been 141 confirmed human cases of the deadly H5N1 strain of bird flu in Asia, including six people in China.

Last week, human trials of the home-grown bird flu vaccine were initiated, with initial results expected within three months.

China to launch new bird flu vaccine for poultry

http://www.stuff.co.nz/stuff/0,2106,3523355a12,00.html

Quote:

27 December 2005

BEIJING: China will begin mass-production of a new bird flu vaccine for poultry by the end of the month that could also help in the development of a vaccine to protect people, state media said yesterday.

The new vaccine - 1 billion shots of which are expected to have been produced by year-end - will be used alongside existing vaccines from next year, the China Daily said, quoting chief veterinarian Jia Youling.

The live vaccine, which will also work against another poultry disease, Newcastle disease, can be delivered orally, nasally or by spraying and will cost a fifth of existing inactivated vaccines, the newspaper said.

Standard flu shots are inactivated, meaning the virus is killed, but live vaccines contain weakened forms of the live virus.

Newcastle outbreaks killed almost 57,000 chickens in China in September, the report said.

"Research and production techniques will provide reference for developing new vaccines for human infections of bird flu," Jia was quoted as saying.

There have been 141 confirmed human cases of the deadly H5N1 strain of bird flu, all of them in Asia, including six in China. Two people have died from bird flu in China, out of 73 known fatalities in Asia.

AdvertisementAdvertisementScientists fear the strain could mutate from a disease that largely affects birds to one that can pass easily between people, leading to a human pandemic.

An intensive poultry vaccination campaign and enforced quarantine of bird flu outbreak areas have shown results in China's fight against bird flu, state media said last week.

Only one county out of 31 to have reported the H5N1 strain of bird flu this year remained under isolation and there had been no new outbreaks for about three weeks, state media said.

Since October, China had also vaccinated more than 5 billion birds.

It began last week human trials of the homegrown bird flu vaccine and initial results are expected within three months.

oneman28 · 12-27-2005, 18:11 PM

http://www.learningbusiness.fi/portal/34/?id=8650

Quote:

economy -Helsinki Region in the 21st place
San Jose, the heart of California’s Silicon Valley heads the WKCI 2005, followed by the US regions of Boston, San Francisco and Hartford. The highest ranked non-US region is Stockholm in Sweden, which climbs seven places to eighth position. Tokyo (23rd) is the highest ranked region outside of North America and Europe. This ranking is in the the 2005 edition of World Knowledge Competitiveness Index (WKCI) published by Robert Huggins Associates.

Nordic countries have improved

Alongside Stockholm, the Nordic regions have almost all improved their rankings for the second year in a row. Both West Sweden (37th) and South Sweden (46th) move up, and are now competitive with the majority of US regions, while Denmark (up eleven places) and Norway (up two places) also perform strongly. Uusimaa (Helsinki) consolidated its phenomenal growth in recent years and is 21st ranked. These rankings are based on very high levels of knowledge-based employment and high levels of research and innovation.

Asia is strong in many ways

The region that has shown the best growth in creating a thriving knowledge-intensive economy is Shanghai, which more than doubled its performance since 2004, and is now ranked second only to Tokyo in terms of patent registrations per capita. (oneman28: I believe it is in Asia only) Also, Mumbai and Bangalore in India have seen improvements in the performance, although they remain towards the bottom of the index.

According to the report, Asia-Pacific is particularly strong in IT and Computer Manufacturing activities, while North America’s strength comes from its spending on R&D and education, and high patenting levels. More access to private equity is also a North American advantage. Europe’s model appears to be an under-performing version of that operating within the North American regions, although it does have strength in high technology sectors such as instrumentation and electrical machinery.

WKCI compares regions globally

The WKCI is an integrated and overall benchmark of the knowledge capacity, capability and sustainability of 125 regions across the globe, and the extent to which this knowledge is translated into economic value, and transferred into the wealth of the citizens of these regions, utilising 19 knowledge economy benchmarks, including employment levels in the knowledge economy, patent registrations, R&D investment by the private and public sector, education expenditure, information and communication technology infrastructure, and access to private equity.

oneman28 · 12-28-2005, 23:40 PM

http://www.plenglish.com/article.asp...D)&language=EN

Quote:

Beijing, Dec 27 (Prensa Latina) Chinese scientists asserted they have created a drug to treat humans infected with bird flu that is better to the widely used Tamiflu, China Daily reports Tuesday.

Like Swiss Tamiflu, made by pharmaceutical group Roche and acknowledged as being effective against infections in humans of the deadly H5N1, the new medicine is a neuraminidase inhibitor that prevents the virus from spreading to other cells.

The treatment, developed by a research group at the Academy of Military Medical Sciences, will be produced by domestic labs and stockpiled for use in the event of a bird flu pandemic.

On December 12, Shanghai Pharmaceutical Group (SPG) became the first Asian company to secure a licence from Roche to produce and sell a generic version of Tamiflu named Oseltamivir.

Chinese scientists are currently seeking for an injectable formula to ease treatment to patients in critical conditions.

mh/ymr/nzp

http://dnaindia.com/report.asp?NewsID=1004316

Quote:

China heightens bird flu vaccine stakes

Venkatesan Vembu

HONG KONG: Given China’s growing influence in the global economy, it’s fair to say that when it catches a cold, the world sneezes. It now turns out that China has just the cure for the chills as well.

The marketplace for a vaccine against the avian flu epidemic, in which Indian pharmaceutical majors Ranbaxy, Cipla and the Hyderabad-based Hetero Drugs have a large stake, just got a bit more crowded. China announced on Monday that it had developed a new vaccine for humans against the killer epidemic, which was better and cheaper than the only known anti-viral drug Tamiflu.

A scientist at a research group of the Academy of Military Medical Sciences was quoted in the local media as saying that clinical experiments had established that the new drug was more effective on humans than Tamiflu, on which the Swiss pharma giant Roche holds the patent.

Roche had only recently given Hetero Drugs a sub-licence to manufacture a generic version of drug for governments of developing countries that wish to stockpile emergency supplies to prepare for an epidemic. Ranbaxy and Cipla too were in talks with Roche to secure the sub-licence, but lost out to Hetero Drugs.

Early in December, the company had granted a similar sub-licence to the Shanghai Pharmaceutical Group.

The new drug, like Tamiflu, is a neuraminidase inhibitor; that is, it prevents the virus from leaving an infected cell by inhibiting an enzyme called neuraminidase. But its molecular structure is thought to be different. And its cost is estimated to be about a fourth of that of Tamiflu.

China Daily quoted the scientist, Li Song, as saying that domestic companies would produce the new medicine, which would be stockpiled in the event of an emergency.

There have been concerns that a new, virulent strain of the bird flu virus may have developed a resistance to Tamiflu, and could be transferred among humans. A recent report in the New England Journal of Medicine had said that four of eight persons with bird flu in Vietnam who were treated with Tamiflu had died. However, the World Health Organisation has said that Tamiflu currently offers the best hope against the infection. That could change if the latest Chinese claim is validated.

On Saturday, Chinese scientists had claimed to have made another breakthrough by developing the world’s first live vaccine for poultry against the epidemic. An Agriculture Ministry official had said on Sunday that scientists at the Harbin Veterinary Research Institute in the north-eastern Heilongjiang province had developed the recombinant bivalent vaccine for poultry after four years’ research employing the reverse genetics technique.

The official was quoted in the local media as saying that the ministry had given fast-track approval of the new live vaccine after scientists established its efficacy and security. Mass-production was approved on December 23, and 1 billion shots would have been produced by December-end, the official said.

oneman28 · 12-29-2005, 11:40 AM

http://en.chinabroadcast.cn/2238/200...118@287868.htm

Quote:

Construction began Thursday on the country's first 1,000 megawatt-level, domestically-built nuclear power plant in Shenzhen, a city in south China's Guangdong Province.

The cornerstone-laying ceremony for the second phase of Ling'ao Nuclear Power Plant or Ling'ao II was led by Chinese Vice Premier Zeng Peiyan and Zhang Dejiang, secretary of Guangdong Provincial Committee of the Communist Party of China (CPC).

Ling'ao II project will have two generating units, each with an installed capacity of 1,000 megawatts. The first unit is scheduled to start operation in December 2010 and the second in August 2011,said sources from China Guangdong Nuclear Power Holding Co. Ltd. (CGNPC).

On completion, the two generating units will generate a total of 150 billion kilowatt hours of electricity each year.

Ling'ao II is based on pressurized water reactor technology with improvement from Chinese scientists. CGNPC spent over 20 years to develop the technology imported from France.

Ling'ao II, one of the key projects included into the state's 10th five-year plan period (2001-2005), is the third commercial nuke power plant in Guangdong, where the country's first nuke power plant -- Daya Bay nuclear power plant --began construction in 1991.

The new plant will be adjacent to the site of Daya Bay nuclear power plant. Ling'ao I project began commercial operation in 2003,with two 990-megawatt generating units.

The nine nuclear generation units in operation include four in Daya Bay and Ling Ao Nuclear Power Plant in Guangdong and five in Qinshan Nuclear Power Plant in east China's Zhejiang Province.

The other two units are under construction in Tianwan Nuclear Power Plant of Jiangsu Province, east China.

Guangdong is also expediating preparation for construction of another nuke power plant in Yangjiang, a coastal city. Construction of the nuclear reactor of that plant will officially begin by the end of 2006, said CGNPC sources.

China plans to increase its installed capacity of nuclear power to 40 million kw by the year 2020, accounting for 4 percent of the country’s total installed capacity at that time.

http://english.people.com.cn/200512/...27_231027.html

Quote:

Following the operational start-ups of 11 nuclear reactors in the south and east, China next year will begin building two nuclear plants which contain two reactors each, in Northeast China's Liaoning Province and East China's Shandong Province.

The Liaoning plant, consisting of two 1,080-MW (megawatt) reactors, will cost US$2.8 billion. It will be the first nuclear base in Northeast China, located at Hongyanhe, the coastal city of Dalian, a senior official from China Guangdong Nuclear Power Group (CGNPG) said.

"We expect to get the final go-ahead (to build the Dalian nuclear plant) from the National Development and Reform Commission (NDRC) by the end of this year," said the official, who did not want to be identified.

CGNPG sources last week said that they plan to start the Dalian project as soon as possible.

The Dalian nuclear plant is scheduled to generate electricity in 2011, the company official said.

CGNPG plans to begin infrastructure construction and design at the Dalian plant within this month, the official said.

According to the investment agreement for the new project in Dalian, CGNPG and China Power Investment Corp (CPI) will each control a 45 per cent stake. The remaining 10 per cent will be equally divided between local companies Liaoning Energy Investment Group and Dalian Construction Investment Co, the CGNPG official said.

For the plant in Shandong Province, CPI has reached an initial agreement with the country's biggest nuclear plant constructor, China National Nuclear Corp (CNNC), to jointly build a nuclear plant at Haiyang.

The Haiyang plant, which contains two 1,000-MW reactors, will process at the same pace as the Dalian plant, CPI director Liu Changqing told China Daily yesterday.

"We have submitted the feasibility study to the NDRC," Liu said.

The Chinese Government has included both projects at Dalian and Haiyang in the country's 11th Five-Year Plan (2006-2011), a CNNC spokesman said last week.

Further details were not available for the Haiyang plant in Shandong.

The Dalian plant will cost less than the previous reactors, since CGNPG will use China's own nuclear technology CPR 1000 in designing the new reactors. This is based on technology adopted in the second phase of the Ling'ao nuclear project in South China's Guangdong Province.

The new reactors at the Dalian plant are expected to cost US$1,300 per kilowatt, compared with the US$1,500 per kilowatt for the Ling'ao phase II, which launched construction earlier this month and contains two 1,000-MW reactors.

"We will be very competitive in the sale prices due to the lower costs," the CGNPG said.

Coal-fired plants, which installed desulphurization facilities, sell their electricity to grid companies at 0.347 yuan (4.28 US cents) per kilowatt-hour in Dalian, according to the CGNPG official.

In order to cut pollution caused by the burning of coal, which fuels more than 70 per cent of the country's electricity generators, the government ordered all the installation of desulphurization equipment in China's coal-fired plants to eliminate sulphur pollutants.

"We can make profit at the same price with these coal-fired plants," the company official said.

Equipment manufacturing and procurement for the new Dalian plant will be open for bid among domestic suppliers, with a small proportion expected to come from foreign companies, the CGNPG official said.

"Domestic suppliers will produce 80 per cent of the equipment including the generation turbines designed for the new plant," he said.

CPI sources earlier said that as many as 10 reactors would be built at the two coastal places in Liaoning and Shandong, with six built at Dalian and four at Haiyang.

Currently, only CNNC and CGNPG are authorized to build nuclear plants in China. Other power companies, including CPI, will only be allowed a stake in the nuclear plant if they intend to participate in the nuclear sector.

Foreseeing great potential in nuclear energy, CGNPG, based in Guangdong, is also planning two more nuclear plants at two places called Taishan and Lufeng in the province.

"Another in the neighbouring Guangxi Zhuang Autonomous Region is also under study," the CGNPG official said.

oneman28 · 12-30-2005, 07:26 AM

http://english.people.com.cn/200512/...27_231157.html

Quote:

A permanent-magnet levitation based wind-energy generating unit, passed the technical appraisal organized by the Guangzhou Department of Science and Technology on Monday.

It has been jointly developed and produced by the Guangzhou Institute of Energy Conversion under the Chinese Academy of Sciences and the Guangzhou Zhongke Hengyuan energy Technology Co Ltd. The institute is the only research institution in the areas of comprehensive research and development of new and renewable energy resources in China.

The generator operates without any control systems. Made independently by China, the successful development of the generator will enable China, or even the world, to make a key breakthrough in the technology of wind-energy generation.

Its comparability testing shows that installed with the permanent magnet levitation bearing, the generator will increase its dynamo output by more than 20 per cent, that is to say, at the same wind speed, the generator will increase generating capacity by 20 per cent.

By People's Daily Online

1st Permanent Magnetic Suspension Wind Power Generator Debuted

http://www.tmcnet.com/usubmit/-1st-p...ec/1244154.htm

Quote:

(SinoCast)GUANGZHOU, Dec 28, 2005 (SinoCast via COMTEX) --The world's first permanent magnetic suspension wind power generator debuted in Guangzhou City, Guangdong Province on December 26.

Its cost is only one tenth of the traditional wind power generator. Moreover, it can generate power by utilizing breeze, that is to say, wind of lower speed in cities can also be used to generate power.

In the past, wind power generators can be only built in the fields with large amount of wind. Experiments show that under the same condition of wind speed, a permanent magnetic suspension wind power generator can generate 20 percent more power compared with a traditional power generator.

China's coastal and western areas are abundant in wind resources, so they can build wind power plants on large scale in the future.

As permanent magnetic suspension wind power generators have advantages in using wind of low speed to generate power, they will be mainly used in two sectors in the future: urban street lamp, speedway, sightseeing lamp system, and large-sized power grids.

From China News, Page 1, Tuesday, December 27, 2005
info@SinoCast.Com

oneman28 · 12-31-2005, 04:17 AM

China approves AVS codec
http://www.c10n.info/archives/268

Quote:

The Ministry of Information has approved China’s proprietary AVS video codec.

December 8th, 2005 Posted by Mark Permanent link

The Peoples Daily tells us that China’s Ministry of Information has approved the AVS video coding standard. This proprietary standard is an attempt to sidestep the increasingly large burden of royalties that China pays for MPEG-2 patent licensing.

At this time the AVS standard is set for internal deployment, for both streaming video and perhaps playable discs. Whether this technology shows up in the export market is still to be determined.

An interesting note at the end of the article:

In its 11th Five-Year Plan, China stated clearly that the development of digital audio-visual sectors would be given priority up to 2010.

The Five-Year Plan has changed quite a bit if it now dictates video codec standards!

http://english.people.com.cn/200512/...15_228158.html

Quote:

Chinese experts have appraised and approved a homegrown sending-receiving system for digital video broadcasting Wednesday in Beijing.

The system, based on digital coding and decoding technology known as AVS, is backed by the Information Ministry, and was co-researched by four institutions and companies based in Beijing and Shanghai.

Experts said that with the approval of the technology, China has developed a comprehensive AVS-based digital system for video broadcasting that involves program producing, broadcasting and receiving.

The technology has involved a couple of innovations that second-generation audio-video coding technology does not have, which paves the way for China to participate in global competition and scale industrialization of the technology.

The system can realize all the functions of digital video broadcasting while doubling or tripling the coding efficiency of MPEG-2 technology and reducing 30-50 percent computing cost, according to experts.

The Chinese Academy of Sciences's Institute of Computing Technology established the Audio and Video Coding Standard Work Group of China in June 2002 and tried to develop technologies with its own intellectual property.

Source: Xinhua

oneman28 · 01-01-2006, 17:36 PM

http://english.people.com.cn/200512/...05_225772.html

Quote:

China has taken the lead among developing countries in the research of genetically modified (GM) plants, an expert has said.

China has been investing 100 million US dollars per year in the research of biotechnological plants since the beginning of this century, and the sum is expected to reach more than 500 million US dollars in 2005, said Shen Guifang, executive deputy director of China High-tech Industrialization Association and researcher of Chinese Academy of Agricultural Sciences.

At present, more than 60 versions of GM plants are approved for field trials and release, including China's staple crops -- rice, maize and wheat, as well as cotton, potato, tomato, soybean, peanut and rape, she said at the "Forum of Industrial Innovation and Agriculture Industrialization" held recently in Yinchuan,capital of northwest China's Ningxia Hui Autonomous Region.

More than 30 versions of GM tomato, cotton, petunia and pimiento have been approved for commercial production. The leading GM plant in China is pest-resistant cotton covering 66 percent of cotton-growing areas, Shen said.

China developed 47 GM plants in 1996, including almost all the main food and forage plants. It has examined and approved 26 GM plants in terms of safety between 1997 and 1999, including 16 of pest-resistant type, nine of antiviral type and one of quality-improved type.

China ranks the fifth -- behind the United States, Argentina, Canada, Brazil - in the amount of genetically modified crops, said a World Health Organization report in June. Last year it had 3.70 million hectares planted, 5 percent of the total transgenic crop area of the world.

Source: Xinhua

oneman28 · 01-03-2006, 04:30 AM

http://www.chinaknowledge.com/news_d...eneral&ID=1713

Quote:

3 January 2006 (CHINA KNOWLEDGE PRESS)

Jan. 3, 2006 (China Knowledge) – China’s research and development (R&D) spending in 2004 reached RMB 196.63 billion, a year-on-year increase of 27.7%, according to the communiqué of the national R&D expenditure released by the National Bureau of Statistics of China.

Of the total R&D spending in 2004, basic research expenditure accounted for RMB 11.72 billion, a year-on-year rise of 33.7%; applied research expenditure accounted for RMB 40.05 billion, a year-on-year increase of 28.6%; and trial research expenditure accounted for RMB 144.87 billion, a year-on-year increase of 27%.

The report also stated that, seven cities and provinces spent more than RMB 10 billion on R&D in 2004, accounting for 65% of the total R&D spending nationwide. These cities and provinces were Beijing, Jiangsu, Guangdong, Shanghai, Shandong, Zhejiang and Liaoning.

Within the RMB 196.63 billion spent on R&D, state-owned science and technology institutes accounted for RMB 43.17 billion, a year-on-year increase of 8.2%, and tertiary schools accounted for RMB 20.09 billion, a year-on-year increase of 23.8%.

oneman28 · 01-03-2006, 04:34 AM

http://english.people.com.cn/200601/...03_232435.html

Quote:

China's Southeast University and Dongda Communication Co. have jointly developed the country's first chip for WCDMA mobile phones, a major step forward in the 3G drive.

Enjoying 16 domestic and foreign patents, the chip, named Noah3000, has passed the systematic test on communication and data transmission, showing it meets the requirements of WCDMA international standards, according to sources with the university.

The new chip has a data transmission speed two to three times faster than those with CDMA 2000 technology. It is also characterized by low power consumption, the sources said.

Source: Xinhua

oneman28 · 01-05-2006, 01:17 AM

http://timesofindia.indiatimes.com/a...ow/1348984.cms

Quote:

Maria Corina Roman, a 40-year-old Danish surgeon, underwent a breast cancer operation in 2001. Two years later she suffered a serious relapse and doctors declared she had just a year to live.

But Roman chanced upon the news that China had approved gene therapy for the treatment of cancer. Without hesitation, she headed to Shenzhen in early 2004.

She was willing to give gene therapy a go at least to try to prolong her life. "I am still living and working in my job as a surgeon in the hospital," said Roman in an email written this month to Peng Zhaohui, chairman and CEO of Shenzhen SiBiono GeneTech.

The company's Gendicine is the world's first commercially available gene therapy treatment.Roman is one of a growing number of patients to benefit from gene therapy, which has drawn increasing attention among medical professionals and the public.

Gene therapy treatment is based on the theory that many serious diseases are caused by genetic dysfunction, either by inheritance or postnatal mutation. Cancer, diabetes and haemophilia are typical diseases caused by genetic dysfunction.

Since research on gene therapy started in the early 1980s, it has since then been enthusiastically embraced by scientists and doctors.

www.chinadaily.com.cn

oneman28 · 01-05-2006, 20:49 PM

http://news.xinhuanet.com/english/20...nt_4014527.htm

Quote:

BEIJING, Jan. 5 (Xinhuanet) -- China has set research and development targets for its defense industry to meet the country's national defense needs and the development of the national economy for the five years through 2010, officials said Thursday.

Jin Zhuanglong, the spokesperson for the Commission of Science, Techonology and Industry for National Defense, said the sector will meet the basic needs of the country's armed services for high-tech weaponry and improve its research and development capability for high technology industrial applications.

China also plans to improve its fundamental capability in basic science and research and in science and development infranstructure in the coming five years, he said.

Jin said China would put in place a new framework that combines its military research and development capability with civilian sectors, including a mechanism allowing the military and civilian sectors to interact with each other to ensure fast progress in the military sector.

On major tasks for the coming five years, Jin listed development of nuclear energy, a manned space program, a lunar probe program, civilian planes, and shipbuilding.

China will work hard to achieve R&D breakthroughs in key technologies for the country's shipbuilding sector while giving priority to the country's three shipbuilding bases along the Pan-Bohai Rim in north China, the Yangtze River Delta and the Pearl River Delta, he said.

The country's military sector has reported an average annual increase of 20 percent in production of civilian goods in the past five years. In 2002, the whole sector became profitable after eight years' of losses. Enditem

12-18-2005, 13:57 PM	#77 (permalink)
oneman28 Banished *Senior Contributor* Join Date: 02-20-05 Posts: 894	China Has Developed New Numerical Controlled Lathe, precision of 0.01 micron THE CNC lathe has a precison of 0.01 micron as thin as 0.1 per cent of a hair,which is the basic facilities to manufacture modern air engine.Obviously ,this is breakthrough of Chinese equipment industry. The CNC Lathe was first developed in the early 1980' in U.S. and has been laid enbargo on China by the western countries for over 20 years. The CNC Lathe developed this time is the masterpieces of "National Engineering Research Center For High-End CNC" .Especially,the price of NC Lathe developed by the Research Center is just 30% of the counterpart of western countries. more introduction: http://lt-cnc.sict.ac.cn/products/en_products.asp CCTV report in Chinese: mms://winmedia.cctv.com.cn/xinwenlia...0051125_16.wmv Last edited by oneman28 : 12-19-2005 at 05:18 AM.